Oxford Instruments on the mend

A sense of relief best explains the mildly positive reaction to flat profits at Oxford Instruments (OXIG) last year. Acquisitions guaranteed modest top-line growth, but after a strong fourth quarter, management is confidently predicting an organic improvement this year. The outlook for government-funded R&D has improved, too.

To continue reading, register today

to enjoy limited access to the following:

  • Daily trading news
  • Funds coverage
  • Features on big investment themes
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now